NCT07433140

Brief Summary

The aim of this study is to observe the effect of administering local anesthetic to the abdominal wall at the beginning or end of surgery under general anesthesia on opioid consumption during surgery. The hypothesis of this study is to demonstrate that administering a rectus sheath block before the surgical procedure under general anesthesia is effective in reducing intraoperative opioid consumption and opioid-related side effects compared to administering it after the surgery is completed.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
2mo left

Started Mar 2026

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Mar 2026Jul 2026

First Submitted

Initial submission to the registry

November 23, 2025

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
18 days until next milestone

Study Start

First participant enrolled

March 15, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2026

Expected
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

3 months

First QC Date

November 23, 2025

Last Update Submit

February 19, 2026

Conditions

Keywords

Robot SurgeryRectus sheath blockNociceptionopioidCancer of Prostate

Outcome Measures

Primary Outcomes (2)

  • Total intraoperatif remifentanil consumption

    Total operative duration

  • Average intraoperative remifentanil consumption

    Total intraoperative remifentail consumption divided by the weight of the patient (kg) and total operative duration (minutes). (mcg/kg/dk)

    Total operative duration

Secondary Outcomes (10)

  • Cumulative opioid consumption at postoperative 1st hour

    From the end of the surgery to the end of the first postoperative hour

  • Cumulative opioid consumption at postoperative 6th hour

    From the end of the surgery to the end of the 6th postoperative hour

  • Cumulative opioid consumption at postoperative 12th hour

    From the end of the surgery to the end of the 12th postoperative hour

  • Cumulative opioid consumption at postoperative 24th hour

    From the end of the surgery to the end of the 24th postoperative hour

  • Pain at postoperative first hour

    At the end of the postoperative 1st hour

  • +5 more secondary outcomes

Study Arms (2)

Preoperative RSB Group

ACTIVE COMPARATOR

The group of patients undergoing robotic prostatectomy surgery who received a rectus sheath block prior to the surgical procedure

Procedure: Early bilateral rectus sheat block

Postoperative RSB Group

ACTIVE COMPARATOR

The group of patients undergoing robotic prostatectomy surgery who received a rectus sheath block after the surgical procedure

Procedure: Late bilateral rectus sheat block

Interventions

Bilateral rectus sheat block will be performed after the anesthesia induction, before the start of the surgery

Preoperative RSB Group

Bilateral rectus sheat block will be performed after the completion of the surgery, before the end of general anesthesia

Postoperative RSB Group

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale sex
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA (American Society of Anesthesiologists) I-III adult patients with prostate cancer and benign prostate diseases scheduled for robotic surgery at Koç University Hospital.

You may not qualify if:

  • \<18 years of age
  • ASA (American Society of Anesthesiologists) IV, V patients
  • Non-elective emergency cases
  • Previous major abdominal/pelvic surgery
  • History of significant psychiatric disorders
  • Patients who may have contraindications to nerve blocks (bleeding diathesis, infection, and local anesthetic allergy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koc University Hospital

Istanbul, 34010, Turkey (Türkiye)

Location

Related Publications (5)

  • Funcke S, Pinnschmidt HO, Brinkmann C, Wesseler S, Beyer B, Fischer M, Nitzschke R. Nociception level-guided opioid administration in radical retropubic prostatectomy: a randomised controlled trial. Br J Anaesth. 2021 Feb;126(2):516-524. doi: 10.1016/j.bja.2020.09.051. Epub 2020 Nov 20.

    PMID: 33228979BACKGROUND
  • Meijer FS, Martini CH, Broens S, Boon M, Niesters M, Aarts L, Olofsen E, van Velzen M, Dahan A. Nociception-guided versus Standard Care during Remifentanil-Propofol Anesthesia: A Randomized Controlled Trial. Anesthesiology. 2019 May;130(5):745-755. doi: 10.1097/ALN.0000000000002634.

    PMID: 30829658BACKGROUND
  • Lumme A, Kalliomaki ML, Harju J, Nordstrom P. Combining Transversus Abdominis Plane and Rectus Sheath Blocks in Open Inguinal Hernia Surgery Anesthesia: A Retrospective Cohort Analysis. World J Surg. 2025 Mar;49(3):626-633. doi: 10.1002/wjs.12481. Epub 2025 Jan 23.

    PMID: 39853690BACKGROUND
  • Cosarcan SK, Gurkan Y, Manici M, Ozdemir I, Kilic M, Esen T, Ercelen O. The effect of ultrasound-guided rectus sheath block on postoperative analgesia in robot assisted prostatectomy: A randomized controlled trial. Medicine (Baltimore). 2024 Apr 26;103(17):e37975. doi: 10.1097/MD.0000000000037975.

    PMID: 38669407BACKGROUND
  • Lavand'homme P, Steyaert A. Opioid-free anesthesia opioid side effects: Tolerance and hyperalgesia. Best Pract Res Clin Anaesthesiol. 2017 Dec;31(4):487-498. doi: 10.1016/j.bpa.2017.05.003. Epub 2017 May 17.

    PMID: 29739537BACKGROUND

MeSH Terms

Conditions

Prostatic NeoplasmsAgnosia

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Rafet O Gorgulu, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Rafet Onur Gorgulu, MD, Resident of Anesthesiology and Reanimation, Department of Anesthesiology, Koc University Hospital

Study Record Dates

First Submitted

November 23, 2025

First Posted

February 25, 2026

Study Start

March 15, 2026

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly available. De-identified data may be shared upon reasonable request to the corresponding author, subject to institutional approval and a data use agreement.

Locations